Birmingham Women's Hospital adopt ZedScan

Friday 29th June 2018

Jenni Byrom tells us why it is important for an adjunct diagnostic technology to be introduced into colposcopy practice and how the recent adoption of ZedScan™ at Birmingham Women's Hospital is helping clinicians prepare for the introduction of the new Primary HPV Screening pathway.

To watch Jenni’s full interview, please click here

Why did Birmingham Women's choose ZedScan?

ZedScan is a unique diagnostic device which uses Electrical Impedance Spectroscopy (EIS) to measure changes in tissue structure caused by the development of cervical intra-epithelial neoplasia (CIN). High grade changes could lead to cervical cancer if left untreated.

Miss Byrom says, "As clinicians, we know colposcopy is a subjective specialty and by using ZedScan to measure something different to what we see with the application of acetowhite, we are given more information which improves our accuracy."

Detecting 'Missed' High Grade Disease


"When we validated ZedScan in our [colposcopy clinic], we found we were picking up over 20% of high grade disease that we would have missed with colposcopy alone. If we are [going to see an increase in referrals] we don't want to be missing high grade disease.

We want to get those women identified, so we can treat them and get them back to normal more quickly, than we would do without the use of ZedScan."


Preparing for the Introduction of Primary HPV Screening



Pilot centre studies have shown an increase in HPV-positive referrals to colposcopy by up to 30% in year one and over 60% in subsequent years. ZedScan can help with better patient management particularly in women with low grade changes.

In her interview, Jenni explains that Birmingham Women's expect to see "a lot of women at the lower end of the spectrum" and how ZedScan can help clinicians be more confident in treating women at first visit or discharging them to routine re-call.